NEW Drug Development ParaDIGmS (NEWDIGS)
 Link to NEWDIGS Profile |
Massachusetts Institute of Technology’s (MIT) NEWDIGS program is a unique collaboration for transforming the global healthcare innovation system to deliver greater value to all stakeholders and to ensure its sustainability.NEWDIGS integrates a coordinated network of innovation test bed environments for “real world” demonstration projects, tightly coordinated with research in science, engineering, management, and clinical medicine, led by MIT and the Harvard-MIT Division of Health Sciences and Technology (HST). This systems approach enables rapid cycle learning in the testing, validation, and continuous improvement of transformational “levers” in technology, process, and policy designed to accelerate our collective capacity to diagnose, treat, and prevent disease.NEWDIGS participants include senior leaders in biopharmaceutical firms, regulators, payors, providers, and other key stakeholders from the global healthcare industry.MIT launched NEWDIGS in 2009 to transform the pharmaceutical development process through a systems approach. The vision for the initiative was developed through a series of cross-stakeholder workshops, and is summarized in a white paper, NEWDIGS: Catalyzing the Transformation of Healthcare Innovation. |
